Rankings
▼
Calendar
HOWL Q2 2020 Earnings — Werewolf Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
HOWL
Werewolf Therapeutics, Inc.
$41M
Q2 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$5M
Net Income
$2M
EPS (Diluted)
$0.25
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$221,000
← FY 2020
All Quarters
Q3 2020 →
